Drug Patent Expirations in April 2009

Drug Patent Expirations in April 2009

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in April 2009

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
ACIPHEX Eisai Medcl Res rabeprazole sodium 5,035,899 Apr 4, 2009
CASODEX Astrazeneca bicalutamide 4,636,505 Apr 1, 2009
GENESA Gensia Automedics arbutamine hydrochloride 5,108,363 Apr 28, 2009
MALARONE Glaxosmithkline atovaquone; proguanil hydrochloride 5,053,432 Apr 1, 2009
MALARONE PEDIATRIC Glaxosmithkline atovaquone; proguanil hydrochloride 5,053,432 Apr 1, 2009
MEPRON Glaxosmithkline atovaquone 5,053,432 Apr 1, 2009
PREFEST Duramed estradiol; norgestimate 5,108,995 Apr 28, 2009
SKELID Sanofi Aventis Us tiludronate disodium 4,980,171 Apr 6, 2009
SPECTRACEF Cornerstone cefditoren pivoxil 4,839,350 Apr 14, 2009
UVADEX Therakos methoxsalen 4,845,075 Apr 11, 2009

Courtesy of DrugPatentWatch.com

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

NO COMMENTS

Leave a Reply